Susceptibility of anaerobic bacteria to 23 antimicrobial agents.
about
Veillonella infections in childrenIdentification and antimicrobial resistance patterns of clinical isolates of Clostridium clostridioforme, Clostridium innocuum, and Clostridium ramosum compared with those of clinical isolates of Clostridium perfringensTreatment of anaerobic infectionIncidence of beta-lactamase production and antimicrobial susceptibility of anaerobic gram-negative rods isolated from pus specimens of orofacial odontogenic infections.Effect of carbon dioxide on in vitro susceptibility of anaerobic bacteria to erythromycin.Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.Variation in susceptibility patterns of species within the Bacteroides fragilis group.Susceptibility of Clostridium botulinum to thirteen antimicrobial agents.Beta-lactamase-producing isolates of Bacteroides species from children.Veillonella parvula meningitis: case report and review of Veillonella infections.Odontogenic infections: Microbiology and managementAnaerobic orbital cellulitis: a clinical and experimental study.Brain abscess in children: microbiology and management.Anaerobic bacteria in upper respiratory tract and other head and neck infections.Non-vertebral Veillonella species septicemia and osteomyelitis in a patient with diabetes: a case report and review of the literatureCurrent antimicrobial therapy of anaerobic infections.Penetration of clindamycin, cefoxitin, and metronidazole into pelvic peritoneal fluid of women undergoing diagnostic laparoscopy.Susceptibilities of Bacteroides and Fusobacterium spp. from foot rot in goats to 10 beta-lactam antibiotics.Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 UComparison of single and combination antimicrobial agents for prevention of experimental gas gangrene caused by Clostridium perfringensAntimicrobial susceptibilities of anaerobic bacteria isolated from female genital tract infections.Comparative activity of ciprofloxacin against anaerobic bacteria.Occurrence of clindamycin-resistant anaerobic bacteria isolated from cultures taken following clindamycin therapy.Survey of anaerobic susceptibility patterns in Canada.Anaerobic lung infections treated with doxycyclinePreliminary safety evaluation of a new Bacteroides xylanisolvens isolateEffect of carbon dioxide and pH on susceptibility of Bacteroides fragilis group to erythromycin.Comparison of the activity of ionophores with other antibacterial agents against anaerobesGingival crevicular fluid levels of clindamycin compared with its minimal inhibitory concentrations for periodontal bacteriaIntravenous metronidazole for treatment of infections involving anaerobic bacteria.Urinary tract and genito-urinary suppurative infections due to anaerobic bacteria.Antibiotic susceptibility of black-pigmented Bacteroides isolates from the human oral cavityComparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.In vitro antibacterial activity of the combination of clindamycin and ceftazidimeQuinolone therapy in the management of infection after irradiation.Susceptibilities of anaerobic bacteria isolated from animals with ovine foot rot to 28 antimicrobial agents.Resistance of Peptostreptococcus spp. to macrolides and lincosamides: inducible and constitutive phenotypesThe nonprophylactic role of cephalosporins in surgeryThe nonprophylactic role of cephalosporins in obstetrics and gynecologyManagement of anaerobic infection.
P2860
Q24642420-C12354C4-2FAE-4242-8357-CF441623A1CFQ24645140-3E6DD558-A521-40BF-B208-7A9914049D05Q28258687-78F0F0E5-A659-44A6-A98E-1544E3FDE9E3Q31907600-8B61F537-6E70-4207-98D3-FB409A2E3243Q33482097-EE1FAC13-B099-46EF-9015-88DE2D970D4CQ33725282-5B841BCB-8536-45F6-A11D-2066D5EBB757Q33727442-E477F54A-A699-4BDA-A804-D4A891EDA124Q33730790-60E54565-BC93-4DAD-A030-CFD0EB96BCCBQ33731582-B8A096DC-1AB0-4059-8A5E-B64575A3E76EQ34052607-3364E6B7-911F-4C3F-A4F9-D42969C07BB5Q34102772-0E554F4F-33A4-482F-86F0-69DFB60E44E6Q34164601-BAFF1D32-5121-44EC-AA54-5E45CD0A4749Q34298488-9C0D05C5-730B-4D39-8413-18CBB3203522Q34644361-1E15218B-0534-4D35-AF60-131D22892362Q35005078-8BA15123-CD51-4947-A983-281B45CB61D4Q35212734-E95DC1C4-E45C-4045-ADED-01E86C4D63A2Q35249334-F30B9432-718C-421D-9053-0CD8DC08EF48Q35252670-39A5B9A4-8575-491F-A8C2-4301F7943F36Q35269353-800B38AC-9C15-405F-99C9-77C203B1CB80Q35536943-1CAF0F63-A755-491F-AFAB-16271CBD04FAQ35570414-EB075A92-5240-40CF-9C1F-7F7149A24907Q35570963-82CDB4E8-5C5B-42D1-97D5-3E2BC06CF258Q35574108-DF3CC9AC-A213-498D-B97E-2A0E0F7D9B51Q35575796-4BD26502-39AD-4643-9246-011C09FD9C14Q35656727-588DBA78-1DA4-450E-8979-AE6FBE5F61D8Q35665562-E2894DB4-6344-4C48-A323-75F25E3AD197Q35668902-5A70B8F8-2FD1-4A78-B656-F2A911969A36Q35669216-1B24F3A6-2005-40E3-B85B-4B48E2489C69Q35669938-32BDE005-557A-4820-9792-AD435FB9C1DEQ35674447-4A97E556-48BC-4D4A-9258-9DB4A2F1EBB3Q35685940-BAA6E0DD-990A-4E58-97FB-CBAB7ACC88C3Q35718902-788D5DC4-AEF5-4F73-B946-98E64423D7EBQ35740560-259D8FB7-AC66-4FBD-AF0D-C70AC7C3C873Q35760281-CA9C24EC-5DFE-4B7E-B0FD-48DB904EE0E4Q35832754-E7A57F43-CA40-4AB5-AEDB-F50A02D75872Q35843692-6798E1AE-ECA3-41C1-8152-001E47D466EEQ35867324-E369D42E-5D27-4960-8448-081F84D1301DQ35876836-C02DD694-5A60-4ECB-9B49-9A1BD6916CEEQ35876845-6EF662B2-6B32-4D65-9A7F-509CBFA64300Q35917352-42D982D5-833E-4E8B-8146-3EE6C827B594
P2860
Susceptibility of anaerobic bacteria to 23 antimicrobial agents.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
1976年论文
@zh
1976年论文
@zh-cn
name
Susceptibility of anaerobic bacteria to 23 antimicrobial agents.
@en
type
label
Susceptibility of anaerobic bacteria to 23 antimicrobial agents.
@en
prefLabel
Susceptibility of anaerobic bacteria to 23 antimicrobial agents.
@en
P2860
P356
P1476
Susceptibility of anaerobic bacteria to 23 antimicrobial agents.
@en
P2093
Finegold SM
P2860
P304
P356
10.1128/AAC.10.4.736
P407
P577
1976-10-01T00:00:00Z